Nice to see TissUse getting a shout out :)

  the FDA wanted data from organs-on-a-chip or some comparable alternative. 

This is the main takeaway from the article imho and great news! ~15 years ago those systems were were not very interesting for pharma companies (bayer used to have a campus a few s-bahn stops away) due to regulators requiring animal tests over those systems.